Patents Assigned to MORS
  • Publication number: 20140350662
    Abstract: A device (200) for implantation in or near an annulus of a tricuspid valve comprising at least one blood flow control element (202) adapted to capture a volume of blood therein. Optionally or alternatively, the blood flow control element is adapted to allow at least some volume of blood (406) to regurgitate through the annulus during at least some part of systole. Optionally or alternatively, the device comprises a relatively rigid annulus with an arc length of less than 300 degrees. Optionally or alternatively, the relatively rigid annulus comprises a plurality of tissue fixation elements positioned along no more than 300 degrees of a circumference of the annulus, for example to avoid damaging conduction pathways between an atria and a chamber.
    Type: Application
    Filed: November 21, 2012
    Publication date: November 27, 2014
    Applicant: Mor Research Applications Ltd.
    Inventor: Mordehay Vaturi
  • Publication number: 20140349874
    Abstract: One or more polymorphisms, including single nucleotide polymorphisms (SNPs), or combinations thereof, for diagnosis of cardiac disease, such as heart failure and atrial fibrillation.
    Type: Application
    Filed: June 9, 2014
    Publication date: November 27, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Offer AMIR, Basil S. LEWIS
  • Patent number: 8895523
    Abstract: Inhibitors of cPLA2? expression are used in the preparation of pharmaceutical compositions for the inhibition of cancer cell proliferation and for the treatment of cancer; the inhibitors are selected from cPLA2?-specific ribozymes, RNA sequences usable for RNA-interference of the cPLA2? gene, and antisense oligonucleotides directed against cPLA2?.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: November 25, 2014
    Assignees: Mor Research Applications Ltd., Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Rachel Levy
  • Publication number: 20140323355
    Abstract: The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.
    Type: Application
    Filed: April 30, 2014
    Publication date: October 30, 2014
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., MOR - RESEARCH APPLICATIONS LTD.
    Inventors: Irun R. COHEN, Meirav PEVSNER-FISCHER, David MARGEL, Jack BANIEL, Ofer YOSSEPOWITCH
  • Publication number: 20140303233
    Abstract: Antisense oligonucleotides against cPLA2 are provided, which are capable of inhibiting cPLA2 expression as well as superoxide production, especially in phagocytes. These antisense oligonucleotides are powerful agents for the treatment of inflammatory conditions, in particular arthritis, as well as in neurodegenerative diseases. The antisense oligonucleotides or compositions comprising the same may be used in methods of treatment of such diseases.
    Type: Application
    Filed: March 10, 2014
    Publication date: October 9, 2014
    Applicants: Ben-Gurion University of the Negev Research and Development Authority, Mor Research Applications Ltd.
    Inventor: Rachel LEVY
  • Publication number: 20140259191
    Abstract: This invention relates to a method of sedating, anaesthetising or euthanising an aquatic organism comprising the step of contacting said organism with linalool, a compositions, a body of water containing thereof and a method of transporting an aquatic organism.
    Type: Application
    Filed: August 22, 2012
    Publication date: September 11, 2014
    Applicant: AQUA-MOR TECHNOLOGIES LTD.
    Inventor: Dani Neifeld
  • Publication number: 20140216464
    Abstract: The invention relates to ovary apparatus for regulating the temperature of the ovary; and shielding it from radiation. The main function of the device is to preserve fertility of women treated with chemotherapy by lowering the ovary temperature while the toxic medications circulate in the patients' blood. The current invention utilizes shielding of the ovary to protect it from radiation, and temperature decrease to further limit the toxic effect of radiation.
    Type: Application
    Filed: February 5, 2013
    Publication date: August 7, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Nicola Nasser
  • Publication number: 20140212896
    Abstract: All neoplastic cells express one or more members of a unique family of cell surface ubiquinone (NADH) oxidase proteins with protein disulfide-thiol interchange activity (ECTO-NOX proteins) that are characteristically inhibited by quinone site inhibitors with anti-cancer activity and a common amino acid sequence disclosed herein that allows for cancer-specific antibody recognition as well as for detection of certain critical reference proteins that provide loading controls. Cancers of different cellular or tissue origins express different ENOX2 cancer isoforms or combinations of isoforms and shed these proteins into the circulation. Herein are disclosed methods both for cancer detection and diagnosis of particular origin, based on the patterns and molecular weights of the isoforms which allow the identification of the cell type and or tissue of origin of the neoplasm. Relative ENOX2 amounts are proportional to tumor burden and provide a reliable measure of response to therapy and disease progression.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 31, 2014
    Applicant: Mor-NuTech, Inc.
    Inventors: D. James Morrè, Brandon Eugene Hostetler, James Jinpal Kim
  • Publication number: 20140199344
    Abstract: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
    Type: Application
    Filed: March 18, 2014
    Publication date: July 17, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Shmuel ARIAD, Jacob GOPAS, Daniel BENHARROCH, Irina LAZAREV
  • Patent number: 8765678
    Abstract: A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed, in particular osteoarthritis and skin diseases. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: July 1, 2014
    Assignee: Mor Research Applications Ltd.
    Inventors: Talia Weinstein, Uzi Gafter, Zvi Nevo, Dror Robinson, Zoharia Evron
  • Patent number: 8758431
    Abstract: Methods and devices for augmenting an atrioventricular valve leaflet is disclosed. A method according to an exemplary embodiment includes piercing a leaflet of the valve to at least a portion of the leaflet's thickness to form a pierced section; and extending the leaflet using said pierced section. A device according to an exemplary embodiment of the invention includes a catheter comprising: a longitudinal tube having a lumen; and a cutting element extendable from the lumen. The cutting element is adapted for forming a limited cut in an atrioventricular valve. A device according to another exemplary embodiment of the invention includes a catheter comprising a longitudinal tube having a lumen; a cutting element extendable from the lumen and adapted for forming a cut in a leaflet of an atrioventricular valve; and a frame, configured to attach to the leaflet and stay attached to the leaflet when the heart beats.
    Type: Grant
    Filed: June 4, 2008
    Date of Patent: June 24, 2014
    Assignee: Mor Research Applications Ltd.
    Inventors: Boris Orlov, Nisan Zef
  • Publication number: 20140170644
    Abstract: A sterile injector comprises a body having a cavity, a hollow needle positionable at a distal end of the injector, a probe holder receivable within the needle, a probe connected to a distal end of the holder, and a driving element axially displaceable within the cavity, for causing relative motion between the probe and the needle upon displacement of the driving element. A sample is injected into a sealed container by displacing the driving element to a first position causing the probe to extend from the needle, applying the extended probe with a sample, displacing the driving element to a second position causing the sample laden probe to be retracted within the needle, piercing a seal of a sealed container with the needle, and displacing the driving element to a third position distally spaced from the first position, after which the probe is injected into the container interior.
    Type: Application
    Filed: August 6, 2012
    Publication date: June 19, 2014
    Applicant: Mor Research Applications Ltd.
    Inventors: Amir Hadayer, Noa Hannah Hadayer, Arie Leonid Marcovich
  • Patent number: 8747931
    Abstract: Generally, a bran processing system for the supercritical carbon dioxide extraction of bran extraction material from bran and fractionation of the bran extraction material. Specifically, a bran processing system for the isolation of a bran extraction material fraction enriched in ferulate-phytosterol esters or oryzanol.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: June 10, 2014
    Assignee: MOR Supercritical, LLC
    Inventors: Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
  • Patent number: 8747106
    Abstract: An energy independent dry corn fractionation ethanol production system which utilizes at least one product of a dry corn fractionation process as fuel to generate power for the production of ethanol. Specifically, power production devices and methods of generating power from dry corn fractionation products for the production of ethanol.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: June 10, 2014
    Assignee: MOR Technology, LLC
    Inventors: Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston
  • Publication number: 20140148752
    Abstract: Provided is a device for use in controlling the liquid outflow from the anterior chamber of the eye, methods of draining aqueous humor from the anterior chamber to the intra-orbital space using the device, methods for controlling the liquid outflow from the anterior chamber of the eye and further surgical methods for implanting the presently described device.
    Type: Application
    Filed: July 18, 2012
    Publication date: May 29, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Gilad Litvin
  • Patent number: 8735368
    Abstract: Antisense oligonucleotides against cPLA2 are provided, which are capable of inhibiting cPLA2 expression as well as superoxide production, especially in phagocytes. These antisense oligonucleotides are powerful agents for the treatment of inflammatory conditions, in particular arthritis, as well as in neurodegenerative diseases. The antisense oligonucleotides or compositions comprising the same may be used in methods of treatment of such diseases.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: May 27, 2014
    Assignees: Mor Research Applications Ltd., Ben-Gurion University of the Negev Research and Development Authority
    Inventor: Rachel Levy
  • Publication number: 20140134069
    Abstract: Supercritical carbon dioxide extraction of corn germ oil from corn germ utilizing extraction conditions adapted to a dry corn fractionation ethanol production process.
    Type: Application
    Filed: December 10, 2013
    Publication date: May 15, 2014
    Applicant: MOR Supercritical, LLC
    Inventors: Kenneth E. DeLine, Daniel L. Claycamp, Daniel Fetherston, Rodger T. Marentis
  • Publication number: 20140128946
    Abstract: The invention relates to ovary apparatus for regulating the temperature of the ovary, and shielding it from radiation. The main function of the device is to preserve fertility of women treated with chemotherapy by lowering the ovary temperature while the toxic medications circulate in the patients' blood. The current invention utilizes shielding of the ovary to protect it from radiation, and temperature decrease to further limit the toxic effect of radiation.
    Type: Application
    Filed: August 3, 2011
    Publication date: May 8, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Nicola Nasser
  • Publication number: 20140087967
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: October 25, 2013
    Publication date: March 27, 2014
    Applicants: Mor Research Applications, Rosetta Genomics Ltd.
    Inventors: Yaron GOREN, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Publication number: 20140046080
    Abstract: Generally, a method of pressure regulated supercritical fluid fractionation of oil seed extraction materials which can be utilized to refine oil seed extraction material established in an amount of supercritical fluid. Specifically, a method of pressure regulated supercritical fluid fractionation of corn germ extraction material to produce a refined corn oil extraction material.
    Type: Application
    Filed: October 15, 2013
    Publication date: February 13, 2014
    Applicant: MOR Supercritical, LLC
    Inventor: Rodger T. Marentis